SAVE Moms and Babies Act of 2026

The SAVE Moms and Babies Act of 2026 prohibits the FDA from approving new abortion drugs or granting investigational exemptions for them. It requires existing approved abortion drugs to be dispensed only in-person by certified healthcare providers in clinics or hospitals (not pharmacies), mandates providers to verify pregnancy duration and handle complications, and enforces strict adverse event reporting to the FDA. The bill directly affects healthcare providers prescribing abortion drugs, patients seeking these medications, and the FDA’s regulatory authority over such drugs. Key provisions include banning use after 70 days gestation, requiring provider certification for specific medical capabilities, and mandating documentation of risks to patients.